TopicalDosed ingredient Cosmetic cross-reference

Sulfur

CAS 7704-34-9

Sulfur (CAS 7704-34-9) is a Phase 4 pharmaceutical compound with 2 bioactivity targets and 105 adverse event associations.

SOURCE NLM DailyMed
Label records
2
SOURCE EMBL-EBI ChEMBL
Bioactivity
3
SOURCE DrugCentral
Adverse signals
105
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Sulfur
CAS Number
7704-34-9
UNII
70FD1KFU70
InChIKey
JLQNHALFVCURHW-UHFFFAOYSA-N
ChEMBL ID
CHEMBL1235452
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
dosed ingredientnatural producttopical
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 4 (Approved)
Approved or marketed human pharmaceutical use is represented in the source phase field.
ChEMBL CHEMBL1235452 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →
SOURCE NLM DailyMed 2 label rows

Drug Label Active Ingredients

Active ingredient and active moiety rows from source drug product labels.

ProductIngredient Active MoietyEffective
AOAO Acne Buster Salicylic Acid Drying Serum SULFUR
70FD1KFU70
 SULFUR 20260506
PEGO Acne Buster Salicylic Acid Drying Serum SULFUR
70FD1KFU70
 SULFUR 20260505
SOURCE EMBL-EBI ChEMBL 3 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- Ki 20300 nM 2 -
Carbonic anhydrase 2
Enzyme
 Ki 4.4 - Homo sapiens
Carbonic anhydrase 1
Enzyme
 Ki 6.22 - Homo sapiens
SOURCE DrugCentral 34 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Drug hypersensitivity 179 96.635 10013700
Broncholithiasis 14 72.317 10065037
Lymph node calcification 14 61.443 10056284
Choroiditis 16 56.066 10008792
Exposure to toxic agent 23 48.226 10053487
Lichen nitidus 8 43.671 10024428
Oesophagitis 32 41.426 10030216
Bronchial wall thickening 14 36.445 10067182
Completed suicide 87 35.193 10010144
Lower respiratory tract infection viral 11 34.667 10065188
Endophthalmitis 18 33.671 10014801
Off label use 68 31.235 10053762
Toxicity to various agents 128 30.888 10070863
Visual acuity reduced 30 29.843 10047531
Soft tissue necrosis 9 28.231 10065769
Dehydration 90 26.914 10012174
Psoriasis 52 26.537 10037153
Radiation oesophagitis 8 26.406 10048899
Intraocular pressure increased 16 22.976 10022806
Chondritis 5 21.316 10008685
Contraindicated product administered 4 21.251 10078504
Dysphagia 53 20.425 10013950
Treatment failure 5 19.386 10066901
Crime 4 17.959 10068954
Sexual abuse 5 17.417 10040461
Eye pain 25 15.282 10015958
Vision blurred 45 14.835 10047513
Vomiting 162 14.668 10047700
Post inflammatory pigmentation change 5 14.319 10036229
Synovitis 5 13.799 10042868
Skin exfoliation 28 13.619 10040844
Ovarian cyst 13 13.551 10033132
Radiation pneumonitis 8 13.488 10037765
Neuropathy peripheral 55 13.016 10029331

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 4 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
SULFUR 10223 SU MTHSPL
Sulfur 10223 SU MTHSPL
sulfur 10223 SU MTHSPL
sulfur 10223 IN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Sulfur used for in pharmaceutical contexts?

Sulfur (CAS 7704-34-9) appears in DailyMed active-ingredient label rows, including AOAO Acne Buster Salicylic Acid Drying Serum, PEGO Acne Buster Salicylic Acid Drying Serum.

What are the known adverse events for Sulfur?

Sulfur has 105 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Drug hypersensitivity, Broncholithiasis, Lymph node calcification, Choroiditis, Exposure to toxic agent. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Sulfur also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Sulfur with EU status "permitted".

What clinical phase is Sulfur in?

Sulfur is rendered with ChEMBL max phase 4 (approved).

What bioactivity targets are documented for Sulfur?

Sulfur has 3 bioactivity rows in this page query. Rendered target entries include Carbonic anhydrase 2, Carbonic anhydrase 1.